120
Participants
Start Date
October 31, 2016
Primary Completion Date
June 30, 2017
Study Completion Date
July 31, 2017
Intravenous acetominophen
One dose if 1 gram intravenous to be given pre-surgery
Ketorolac, intramuscular
One dose of 60 mg Intramuscular to be given at time of skin closure
Bupivacaine, subcutaneous
Inject 20 mL of 0.25% bupivacaine at the site of anticipated skin incision.
Normal saline
Normal saline will be given intravenously, intra-muscularly, and subcutaneously in the same volume as the study drugs for the patients in the placebo group.
University of Texas Medical Branch, Galveston
The University of Texas Medical Branch, Galveston
OTHER